• In May 2026, Hyliion Holdings Corp. announced that the U.S. Navy’s Office of Naval Research, in partnership with DARPA, selected the unmanned USX-1 Defiant as a candidate test vessel for four 200 KW keel‑cooled KARNO Cores, forming an 800 KW drop‑in onboard power system for sea trials.
• This defense‑focused deployment positions Hyliion’s modular, low‑maintenance KARNO generator as a potential fit for long‑duration autonomous naval operations requiring distributed, redundant shipboard power.
• Now we’ll examine how KARNO’s selection for the USX-1 Defiant unmanned vessel trials could influence Hyliion’s investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 12 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Hyliion Holdings Investment Narrative Recap

To own Hyliion, you have to believe the KARNO generator can move from promising trials to meaningful commercial sales before the current cash burn becomes a bigger problem. The USX-1 Defiant selection reinforces the military energy security catalyst, but its impact on the near term commercialization timetable and certification milestones looks incremental rather than a clear shift in the most important upcoming catalyst or the key execution risk.

The most relevant recent announcement here is Hyliion’s reaffirmed 2026 guidance for about US$10 million of revenue from R&D services and potential initial 200 kW KARNO Power Module sales. The Defiant trials sit alongside earlier Navy load profile tests and multi fuel demonstrations, and together these programs frame how quickly Hyliion might turn today’s defense and industrial interest into firm orders once certification and field deployments are in place.

Yet while the defense work is encouraging, investors should also be aware that any delay in UL certification or Navy deployment timelines could...

Hyliion Holdings' narrative projects $154.7 million revenue and $18.3 million earnings by 2028. This requires 230.8% yearly revenue growth and a $76.7 million earnings increase from -$58.4 million today.

Uncover how Hyliion Holdings' forecasts yield a $5.00 fair value, a 28% downside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span about US$3.50 to just over US$9.39 per share, showing very different expectations. When you set that spread against Hyliion’s need to convert early defense trials into certified, revenue generating KARNO deployments, it underlines why reviewing multiple viewpoints on the company’s execution risk and timing could be useful.

Explore 4 other fair value estimates on Hyliion Holdings - why the stock might be worth as much as 34% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Hyliion Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Hyliion Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hyliion Holdings' overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

• Capitalize on the AI infrastructure supercycle with our selection of the 47 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Find 46 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.